Moderna and other groups get USD60m to develop Ebola vaccine

BENGALURU: Global health organisation CEPI will give roughly USD60 million to Moderna and to two other groups to accelerate the development of shots against Ebola Bundibugyo, the deadly virus that has swept through eastern Democratic Republic of Congo.

The Coalition for Epidemic Preparedness Innovations was one of the early investors that helped to develop a vaccine at the height of the COVID-19 pandemic.

Richard Hatchett, head of CEPI, told Reuters it was possible to get vaccines against Ebola Bundibugyo ready for trials within a couple of months.